{
  "catalysts": [
    {
      "ticker": "QDEL",
      "current_price": 22.94,
      "market_cap": "$1.6B",
      "conviction_score": 9,
      "thesis": "Classic 'Cluster Buying' signal where the CEO, CFO, and a Director all purchased shares on the open market (filed late Friday, Feb 13), signaling strong internal conviction that the stock is undervalued.",
      "catalyst_details": "Insider Cluster Buying: CEO, CFO, and Director purchased ~$570k worth of stock on Feb 13, 2026.",
      "absorption_status": "Unpriced",
      "earnings_date": "2026-05-06",
      "relative_volume": "1.5x",
      "stop_loss_trigger": "$21.34",
      "sentiment": "Bullish",
      "prediction_market": "High probability of reversal",
      "recency_proof": "SEC Form 4 filings dated 2026-02-13",
      "risk": "Medical device sector volatility",
      "expected_upside": "15-20%",
      "mispricing_evidence": "Stock down 45% YoY; insiders stepping in at these lows suggests a floor.",
      "x_sentiment": "Bullish chatter on insider tracking accounts",
      "hold_time_estimate": "2-4 Weeks",
      "atr_value": 1.93,
      "calculated_stop_loss": 21.34,
      "breakeven_trigger": 25.35,
      "shares_count": 4.3582,
      "position_cost": 100.0,
      "risk_r_unit": 1.61
    },
    {
      "ticker": "LGIH",
      "current_price": 56.2,
      "market_cap": "$1.4B",
      "conviction_score": 8,
      "thesis": "Reported a Q4 earnings beat ($0.97 vs $0.96 est) this morning with positive forward commentary. The stock is up only ~1.8%, leaving room for a PEAD move as the market digests the beat.",
      "catalyst_details": "Q4 Earnings Beat reported Feb 17, 2026 (Pre-Market).",
      "absorption_status": "Run-up / Early PEAD",
      "earnings_date": "2026-02-17",
      "relative_volume": "2.0x",
      "stop_loss_trigger": "$52.27",
      "sentiment": "Bullish",
      "prediction_market": "Moderate",
      "recency_proof": "Earnings release 2026-02-17",
      "risk": "Interest rate sensitivity",
      "expected_upside": "5-10%",
      "mispricing_evidence": "Beat estimates but price reaction (<2%) is muted compared to historical volatility.",
      "x_sentiment": "Positive reactions to margin improvement",
      "hold_time_estimate": "2-3 Days",
      "atr_value": 3.05,
      "calculated_stop_loss": 52.27,
      "breakeven_trigger": 62.1,
      "shares_count": 1.7794,
      "position_cost": 100.0,
      "risk_r_unit": 3.93
    },
    {
      "ticker": "NCLH",
      "current_price": 23.39,
      "market_cap": "$9.8B",
      "conviction_score": 8,
      "thesis": "Activist investor Elliott Investment Management has built a ~10% stake, which often precedes strategic shifts, cost-cutting, or sale rumors that drive stock prices higher.",
      "catalyst_details": "Activist Stake (Elliott) reported Feb 17, 2026.",
      "absorption_status": "Partially Priced (Up 7.5%)",
      "earnings_date": "2026-02-24",
      "relative_volume": "4.5x",
      "stop_loss_trigger": "$21.75",
      "sentiment": "Bullish",
      "prediction_market": "High",
      "recency_proof": "WSJ Report 2026-02-17",
      "risk": "Regulatory hurdles or deal failure",
      "expected_upside": "15-25%",
      "mispricing_evidence": "Valuation discount relative to peers; activist involvement typically closes this gap.",
      "x_sentiment": "Very Bullish on M&A speculation",
      "hold_time_estimate": "2-4 Weeks",
      "atr_value": 1.47,
      "calculated_stop_loss": 21.75,
      "breakeven_trigger": 25.85,
      "shares_count": 4.2753,
      "position_cost": 100.0,
      "risk_r_unit": 1.64
    },
    {
      "ticker": "SCSC",
      "current_price": 36.64,
      "market_cap": "$767M",
      "conviction_score": 7,
      "thesis": "Director Charles Mathis increased his stake by ~32% (buying 6,000 shares) following an earnings miss, suggesting the sell-off was an overreaction and value is present.",
      "catalyst_details": "Director Insider Buy filed Feb 13, 2026.",
      "absorption_status": "Unpriced / Reversal",
      "earnings_date": "2026-05-04",
      "relative_volume": "1.2x",
      "stop_loss_trigger": "$34.08",
      "sentiment": "Bullish",
      "prediction_market": "Low visibility",
      "recency_proof": "SEC Form 4 filing 2026-02-13",
      "risk": "Recent earnings miss overhang",
      "expected_upside": "10-15%",
      "mispricing_evidence": "Insider buying aggressively into the dip creates a divergence between price action and insider sentiment.",
      "x_sentiment": "Quiet",
      "hold_time_estimate": "2-4 Weeks",
      "atr_value": 2.28,
      "calculated_stop_loss": 34.08,
      "breakeven_trigger": 40.49,
      "shares_count": 2.7293,
      "position_cost": 100.0,
      "risk_r_unit": 2.56
    }
  ]
}